PCK Shares PainChek Limited
ASX · ASXLast in our picks 2026-09-25 — not in the current list; analysis below is from that screen
Not a relevant semiconductor investment; included only if category coverage is broad.
Signal breakdown
- ▸No meaningful semiconductor catalyst; very weak thematic fit.
- ▾Below 50-day MA (-6.86%)
- ▾Near 52-week low (0.5% of range)
Is PCK a buy right now?
Trend: PCK is trading below the 50-day average (-30.00%), RSI 44 — neutral momentum, with a 3-month return of -27.08%.
Valuation & quality: fundamentals show net margin -238.8%, revenue growth 17.9% year on year.
Our screen: WATCH (score 0) — Not a relevant semiconductor investment; included only if category coverage is broad.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -5.90% | +0.00% | -12.50% | -28.60% | +0.00% | -10.00% | +11.10% | -30.00% |
Fundamentals
Technical signals
About PainChek Limited
PainChek Limited engages in the development and commercialization of mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally.
Sector: Healthcare · Industry: Health Information Services · Australia · Website
Related Semiconductors picks
Browse: all ASX stocks · Semiconductors picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.